CDK9-IN-27
CDK9-IN-27 is a potent CDK9 inhibitor (IC50 = 0.424 μM) that induces apoptosis and S-phase arrest in cancer cells. It demonstrates cytotoxic activity against HepG2, HCT-116, and MCF-7 cell lines, supporting its application in oncology research for studying transcriptional regulation and cancer cell proliferation.
Product Specifications
Field of Research
Cell Biology, Epigenetics & Chromatin
Molecular Formula
C23H18ClN5O3
Molecular Weight
447.87
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
